Jiangsu Hansoh Pharmaceutical Group is an API manufacturer based in China. It holds 17 active US drug master files and 3 valid CEPs across a filed portfolio of 15 molecules. Its filings concentrate with MINSA (CR), ARCSA (EC) and JFDA (JO). Its GMP standing is certified by EMA and TMDA (TZ).
| Site | FDA FEI |
|---|---|
| Lianyungang City, China | Not on file |
| JIANGSU, China | Not on file |
| Lianyungang, China | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Pemetrexed | SFDA (Saudi Arabia), US FDA | 4 |
| Gemcitabine | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Micafungin | SFDA (Saudi Arabia), US FDA | 3 |
| Vinorelbine | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Azacitidine | US FDA | 1 |
| Bortezomib | US FDA | 1 |
| Carfilzomib | US FDA | 1 |
| Dapagliflozin | US FDA | 1 |
| Decitabine | US FDA | 1 |
| Degarelix | US FDA | 1 |
| Enzalutamide | US FDA | 1 |
| Fulvestrant | US FDA | 1 |
| Icatibant | US FDA | 1 |
| Nintedanib | US FDA | 1 |
| Pemetrexed Disodium | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 6 | None |
| ARCSA (EC) | 2 | None |
| JFDA (JO) | 2 | None |
| UZPHARM (UZ) | 1 | None |
| EMA | None | 4 |
| TMDA (TZ) | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Jiangsu Hansoh Pharmaceutical Group comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.